title: The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin-resistant Staphylococcus aureus USA400 in Rio de Janeiro, Brazil.
abstract: Staphylococcus aureus is the main causal pathogen of infective endocarditis (IE), which may have distinct origins, namely, community, nosocomial, or non-nosocomial healthcare-associated (NNHCA). We report the first case of NNHCA-IE caused by methicillin-resistant S. aureus strain USA400/SCCmec IV in which the combination therapy of rifampin and vancomycin had a favorable outcome for the patient.
authors: Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
authors: P V
authors: PV
authors: Damasco
authors: F S
authors: FS
authors: Cavalcante
authors: R C
authors: RC
authors: Chamon
authors: D C
authors: DC
authors: Ferreira
authors: S S
authors: SS
authors: Rioja
authors: M V
authors: MV
authors: Potsch
authors: M P
authors: MP
authors: Pastura
authors: V D
authors: VD
authors: Marques
authors: M B
authors: MB
authors: Castier
authors: E A
authors: EA
authors: Marques
authors: K R N
authors: KR
authors: Santos
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001938:Brazil; D017548:Echocardiography, Transesophageal; D004696:Endocarditis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D005838:Genotype; D006268:Health Facilities; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D058889:Molecular Typing; D012293:Rifampin / Q000008:administration & dosage; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D012293:Rifampin